Time-domain quantitation of 1H short echo-time signals: background accommodation

Quantitation of 1H short echo-time signals is often hampered by a background signal originating mainly from macromolecules and lipids. While the model function of the metabolite signal is known, that of the macromolecules is only partially known. We present time-domain semi-parametric estimation approaches based on the QUEST quantitation algorithm (QUantitation based on QUantum ESTimation) and encompassing Cramér–Rao bounds that handle the influence of ‘nuisance’ parameters related to the background. Three novel methods for background accommodation are presented. They are based on the fast decay of the background signal in the time domain. After automatic estimation, the background signal can be automatically (1) subtracted from the raw data, (2) included in the basis set as multiple components, or (3) included in the basis set as a single entity. The performances of these methods combined with QUEST are evaluated through extensive Monte Carlo studies. They are compared in terms of bias–variance trade-off. Because error bars on the amplitudes are of paramount importance for diagnostic reliability, Cramér–Rao bounds accounting for the uncertainty caused by the background are proposed. Quantitation with QUEST of in vivo short echo-time 1H human brain with estimation of the background is demonstrated.

[1]  U. Klose,et al.  Reliable detection of macromolecules in single‐volume 1H NMR spectra of the human brain , 2001, Magnetic resonance in medicine.

[2]  P. Luyten,et al.  Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge , 1988, Magnetic resonance in medicine.

[3]  S. Provencher.  Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.

[4]  Robert Bartha,et al.  Quantitative proton short‐echo‐time LASER spectroscopy of normal human white matter and hippocampus at 4 Tesla incorporating macromolecule subtraction , 2003, Magnetic resonance in medicine.

[5]  Dirk van Ormondt,et al.  Cramer√© Rao-Bound Analysis of Spectroscopic Signal Processing Methods , 2002 .

[6]  J. Slotboom,et al.  Quantitative 1H‐magnetic resonance spectroscopy of human brain: Influence of composition and parameterization of the basis set in linear combination model‐fitting , 2002, Magnetic resonance in medicine.

[7]  V. Govindaraju,et al.  Automated spectral analysis III: Application to in Vivo proton MR Spectroscopy and spectroscopic imaging , 1998, Magnetic resonance in medicine.

[8]  K. Behar,et al.  Analysis of macromolecule resonances in 1H NMR spectra of human brain , 1994, Magnetic resonance in medicine.

[9]  Vanhamme,et al.  Improved method for accurate and efficient quantification of MRS data with use of prior knowledge , 1997, Journal of magnetic resonance.

[10]  D J Drost,et al.  Factors affecting the quantification of short echo in‐vivo 1H MR spectra: prior knowledge, peak elimination, and filtering , 1999, NMR in biomedicine.

[11]  C Boesch,et al.  Characterization of the macromolecule baseline in localized 1H‐MR spectra of human brain , 2001, Magnetic resonance in medicine.

[12]  G. Krueger,et al.  Time-Domain Fitting of 1 HMR Spectra of the Human Brain : A Model-Free Integration of the Macromolecular Baseline , 2002 .

[13]  S. Provencher.  Estimation of metabolite concentrations from localized in vivo proton NMR spectra , 1993, Magnetic resonance in medicine.

[14]  D. van Ormondt,et al.  Background-signal Parameterization in In Vivo MR Spectroscopy , 2002 .

[15]  Wolfgang Grodd,et al.  Parameterized evaluation of macromolecules and lipids in proton MR spectroscopy of brain diseases , 2003, Magnetic resonance in medicine.

[16]  J. Pettegrew,et al.  Postprocessing method to segregate and quantify the broad components underlying the phosphodiester spectral region of in vivo 31P brain spectra , 2001, Magnetic resonance in medicine.

[17]  B J Soher,et al.  Automated spectral analysis I: Formation of a priori information by spectral simulation , 1998, Magnetic resonance in medicine.

[18]  B J Soher,et al.  Automated spectral analysis II: Application of wavelet shrinkage for characterization of non‐parameterized signals , 1998, Magnetic resonance in medicine.

[19]  James C. Spall,et al.  Parameter identification for state-space models with nuisance parameters , 1990 .

[20]  J. Lachin,et al.  Corrections for Bias in Maximum Likelihood Parameter Estimates Due to Nuisance Parameters , 2003 .

[21]  P. Williamson,et al.  The use of a priori knowledge to quantify short echo in vivo 1h mr spectra , 1995, Magnetic resonance in medicine.

[22]  V. Govindaraju,et al.  Proton NMR chemical shifts and coupling constants for brain metabolites , 2000, NMR in biomedicine.

[23]  Dirk van Ormondt,et al.  Semiparametric Estimation for Metabolomics , 2000 .

[24]  B J Soher,et al.  Representation of strong baseline contributions in 1H MR spectra , 2001, Magnetic resonance in medicine.

[25]  D. van Ormondt,et al.  Time-Domain Quantitation with a Metabolite Basis Set , 2003 .